BYLB yields 3.65% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, BYLB + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BYLB + ABBV for your $10,000?
Boyle Bancorp, Inc. operates as the holding company for Farmers National Bank that provides a range of commercial and personal banking services in the United States. It offers checking and savings accounts, money market accounts, certificates of deposits, and IRAs; and auto, recreational vehicle, boat, ATVs/UTVs, CD, marketable security, construction, FHA, VA, home equity, and rural housing loans; fixed rate and adjustable-rate mortgages; business loans, including commercial real estate, multi-family dwellings, commercial construction, business equipment, and lines of credit; agriculture loans comprising farm equipment financing, real estate/farm improvement, operating, refinancing, and sweep loans/accounts; and equine loans consists of mare/stallion and farm financing. The company also provides automated clearing house, remote deposit capture, reorder checks, safe deposit boxes, wire transfer, and overdraft protection services, as well as debit and credit cards; and investment and wealth, brokerage, insurance, ATM, and online and mobile banking services. It operates 12 banking locations in Boyle, Casey, Garrard, Lincoln, and Mercer counties of Kentucky. Boyle Bancorp, Inc. was founded in 1879 and is based in Danville, Kentucky.
Full BYLB Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.